January 28, 2015 7:44 AM ET


Company Overview of Ceres Ventures, Inc., Prior to Reverse Merger with BluFlow Technologies, Inc.

Executive Profile

Charles K. Lee M.D., Ph.D.

AgeTotal Calculated CompensationThis person is connected to 1 Board Members in 1 different organizations across 1 different industries.

See Board Relationships


Mr. Charles K. Lee, MD,Ph.D. served as Director of Pharmacokinetics of KV Pharmaceuticals. Dr. Lee served as the KV Pharmaceuticals's liaison to the FDA in the United States, and foreign health authorities in Canada and Japan. He coordinated and supervised the preparation of numerous applications to the FDA, including Investigational New Drug, New Drug Application, and Abbreviated New Drug Application submissions of KV Pharmaceuticals. While at KV Pharmaceuticals, Dr. ...

Corporate Headquarters

100 Overlook Drive
Princeton, New Jersey 08540

United States

Phone: 800-611-3388
Fax: 604-659-5029

Board Members Memberships

There is no Board Members Memberships data available.


University of California-San Francisco
Auburn University

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Ceres Ventures, Inc., Prior to Reverse Merger with BluFlow Technologies, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.